Evidence map›Paper›PMID 41201255›Full record

ReviewJournal of the American Society of Nephrology : JASN2026

Responsible Use of Artificial Intelligence to Improve Kidney Care: A Statement from the American Society of Nephrology.

Navdeep Tangri, Wisit Cheungpasitporn, Stanley D Crittenden, Alessia Fornoni, Carmen A Peralta, Karandeep Singh, Len A Usvyat, Amy D Waterman, American Society of Nephrology (ASN) Artificial Intelligence (AI) Workgroup

Abstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Enhancing Education for Nephrologists in Fellowship and Practice.Journal of the American Society of Nephrology : JASN · 2026
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Navdeep TangriDepartment of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Wisit CheungpasitpornMayo Clinic, Rochester, Minnesota.ORCID 0000-0001-9954-9711
Stanley D CrittendenQuantum Health, Redondo Beach, California.
Alessia FornoniDepartment of Medicine, University of Miami, Miami, Florida.ORCID 0000-0002-1313-7773
Carmen A PeraltaHabitat Health, San Mateo, California.ORCID 0000-0003-4265-2392
Karandeep SinghJoan and Irwin Jacobs Center for Health Innovation, University of California, San Diego, San Diego, California.ORCID 0000-0001-8980-2330
Len A UsvyatRenal Research Institute, New York, New York.ORCID 0000-0003-2745-1429
Amy D WatermanHouston Methodist Hospital, Houston, Texas.ORCID 0000-0002-7799-0060
American Society of Nephrology (ASN) Artificial Intelligence (AI) Workgroup

Funding

AIM-AHEAD Coordinating Center - All Four CoresOT2OD032581 · OD · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI Paul Avillach, Bettina M. Beech · 2021 to 2026
$168.7M
NIH HHS OT2 OD032581
6 · The paper itself

Abstract

Artificial intelligence (AI) is rapidly transforming the delivery of kidney care through predictive analytics, machine learning, deep learning, and generative AI technologies. To meet this challenge, the American Society of Nephrology convened an AI Workgroup to provide a framework for the responsible use of AI in nephrology. The group outlines foundational principles to guide AI development: prioritizing patient benefit, ensuring clinician oversight, and advancing innovation in high-burden disease areas. Its set of foundational assumptions are grounded in the physician always being in the loop and an overarching goal to benefit patients with kidney diseases. This review provides an overview of the clinical uses of AI in nephrology and offers practical guidance for nephrologists seeking to incorporate AI into CKD and AKI management, dialysis, and transplantation care. It also highlights key challenges-such as data quality, equity, transparency, and clinical integration-that must be addressed to ensure the responsible and effective implementation of AI in kidney care.

Indexed as

Artificial IntelligenceKidney DiseasesNephrologyAcute Kidney InjuryHumansKidney TransplantationSocieties, MedicalUnited Statesartificial intelligencekidneykidney diseasekidney failurenephrology

Identifiers

PMID41201255
PMCPMC13065138

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.